As of 2026-09-16, the Relative Valuation of Innocan Pharma Corp (INNO.CN) is 0.17 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 2.35 CAD, the upside of Innocan Pharma Corp based on Relative Valuation is -92.7%.
The range of the Relative Valuation is (0.04) - 0.78 CAD.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 2.0x | 0.1x |
| Forward P/E multiples | 7.5x - 18.9x | 9.4x |
| Fair Price | (0.04) - 0.78 | 0.17 |
| Upside | -101.6% - -66.8% | -92.7% |
| Date | P/E |
| 2026-09-11 | -5.94 |
| 2026-09-10 | -5.94 |
| 2026-09-09 | -5.94 |
| 2026-09-08 | -6.98 |
| 2026-09-04 | -6.84 |
| 2026-09-03 | -6.98 |
| 2026-09-02 | -7.25 |
| 2026-09-01 | -7.25 |
| 2026-08-31 | -7.25 |
| 2026-08-28 | -6.45 |
| 2026-08-27 | -6.51 |
| 2026-08-25 | -6.54 |
| 2026-08-24 | -6.69 |
| 2026-08-21 | -6.69 |
| 2026-08-19 | -6.24 |
| 2026-08-17 | -6.84 |
| 2026-08-13 | -6.84 |
| 2026-08-12 | -6.69 |
| 2026-08-11 | -6.84 |
| 2026-08-10 | -6.54 |
| 2026-08-07 | -7.43 |
| 2026-08-06 | -7.43 |
| 2026-08-05 | -6.54 |
| 2026-08-04 | -7.76 |
| 2026-07-31 | -8.77 |
| 2026-07-30 | -8.03 |
| 2026-07-29 | -7.43 |
| 2026-07-28 | -6.48 |
| 2026-07-27 | -8.77 |
| 2026-07-24 | -8.03 |
| 2026-07-22 | -9.21 |
| 2026-07-21 | -9.51 |
| 2026-07-16 | -9.51 |
| 2026-07-14 | -10.40 |
| 2026-07-13 | -9.81 |
| 2026-07-03 | -10.40 |
| 2026-07-02 | -7.13 |
| 2026-06-30 | -7.43 |
| 2026-06-29 | -7.97 |
| 2026-06-26 | -7.64 |
| 2026-06-25 | -8.17 |
| 2026-06-22 | -8.62 |
| 2026-06-18 | -9.36 |
| 2026-06-17 | -9.51 |